Cite

HARVARD Citation

    Hall, P. et al. (n.d.). P084 Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2– Advanced Breast Cancer (ABC) in UK Real-world Settings. Breast. pp. S47-. [Online]. 
  
Back to record